| Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials A Esteva, J Feng, D van der Wal, SC Huang, JP Simko, S DeVries, ... NPJ digital medicine 5 (1), 71, 2022 | 110 | 2022 |
| Artificial intelligence predictive model for hormone therapy use in prostate cancer DE Spratt, S Tang, Y Sun, HC Huang, E Chen, O Mohamad, AJ Armstrong, ... NEJM evidence 2 (8), EVIDoa2300023, 2023 | 69 | 2023 |
| Building a foundation for data-driven, interpretable, and robust policy design using the ai economist A Trott, S Srinivasa, D van der Wal, S Haneuse, S Zheng arXiv preprint arXiv:2108.02904, 2021 | 34 | 2021 |
| Biological data annotation via a human-augmenting AI-based labeling system D van der Wal, I Jhun, I Laklouk, J Nirschl, L Richer, R Rojansky, ... NPJ digital medicine 4 (1), 145, 2021 | 30 | 2021 |
| An AI-derived digital pathology-based biomarker to predict the benefit of androgen deprivation therapy in localized prostate cancer with validation in NRG/RTOG 9408. DE Spratt, Y Sun, D Van der Wal, SC Huang, O Mohamad, AJ Armstrong, ... Journal of Clinical Oncology 40 (6_suppl), 223-223, 2022 | 13 | 2022 |
| Dutch nao team-technical report D van der Wal, P Kronemeijer, C Lagrand Technical report, University of Amsterdam, 2017 | 9 | 2017 |
| Team qualification document for robocup 2017, nagoya C Lagrand, S Negrijn, P de Kok, M van der Meer, D van der Wal, ... Japan. Technical report, University of Amsterdam, Science Park 904 …, 2016 | 9 | 2016 |
| Improved multimodal fusion for small datasets with auxiliary supervision G Holste, D van der Wal, H Pinckaers, R Yamashita, A Mitani, A Esteva 2023 IEEE 20th international symposium on biomedical imaging (ISBI), 1-5, 2023 | 8 | 2023 |
| Detecting a checkered black and white football. honour’s project report C Lagrand, D van der Wal, P Kronemeijer Universiteit van Amsterdam (February 2017), 2017 | 8 | 2017 |
| 1767MO External validation of a digital pathology-based multimodal artificial intelligence (MMAI)-derived model in high-risk localized (M0)/metastatic (M1) prostate cancer (PCa … CTA Parker, L Mendes, E Grist, V Liu, D Van der Wal, JR Griffin, E Chen, ... Annals of Oncology 34, S956, 2023 | 5 | 2023 |
| Development and validation of a prognostic AI biomarker using multi-modal deep learning with digital histopathology in localized prostate cancer on NRG Oncology phase III … A Esteva, J Feng, SC Huang, D Van der Wal, J Simko, S DeVries, E Chen, ... Journal of Clinical Oncology 40 (6_suppl), 222-222, 2022 | 5 | 2022 |
| Team Qualification Document for RoboCup 2018, Montreal C Lagrand, S Negrijn, M van der Meer, D van der Wal, L Petrini, ... Canada. Technical report, University of Amsterdam, Science Park 904 …, 2018 | 5 | 2018 |
| Prostate cancer risk in African American men evaluated via digital histopathology multi-modal deep learning models developed on NRG Oncology phase III clinical trials. M Roach, J Zhang, A Esteva, O Mohamad, D Van der Wal, J Simko, ... Journal of Clinical Oncology 40 (16_suppl), 108-108, 2022 | 4 | 2022 |
| Stochastic Activation Actor Critic Methods W Shang, D van der Wal, H van Hoof, M Welling Joint European Conference on Machine Learning and Knowledge Discovery in …, 2019 | 4 | 2019 |
| Prostate cancer risk stratification in NRG Oncology phase III randomized trials using multi-modal deep learning with digital histopathology JD Tward, J Zhang, A Esteva, O Mohamad, D van der Wal, J Simko, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), S2, 2022 | 3 | 2022 |
| Dutch Nao Team T Wiggers, D van der Wal, HL gezegd Deprez, W Zwerink, P Kronemeijer, ... Technical report, Universiteit van Amsterdam, 2020 | 3 | 2020 |
| Prostate cancer risk stratification in NRG Oncology phase III randomized trials using multimodal deep learning with digital histopathology JD Tward, HC Huang, A Esteva, O Mohamad, D van der Wal, JP Simko, ... JCO Precision Oncology 8, e2400145, 2024 | 2 | 2024 |
| Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials A Esteva, J Feng, D van der Wal, SC Huang, JP Simko, S DeVries, ... npj Digital Medicine 6 (1), 27, 2023 | 1 | 2023 |
| Advantage Actor-Critic Methods for CarRacing D van der Wal, W Shang | 1 | 2018 |
| AI-enhanced data labeling CA Esteva, DS van der Wal US Patent 12,079,311, 2024 | | 2024 |
